Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Nov 4;11(1):21677.
doi: 10.1038/s41598-021-00523-z.

Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD

Collaborators, Affiliations
Observational Study

Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD

Kathrin Burgmaier et al. Sci Rep. .

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is characterized by bilateral fibrocystic changes resulting in pronounced kidney enlargement. Impairment of kidney function is highly variable and widely available prognostic markers are urgently needed as a base for clinical decision-making and future clinical trials. In this observational study we analyzed the longitudinal development of sonographic kidney measurements in a cohort of 456 ARPKD patients from the international registry study ARegPKD. We furthermore evaluated correlations of sonomorphometric findings and functional kidney disease with the aim to describe the natural disease course and to identify potential prognostic markers. Kidney pole-to-pole (PTP) length and estimated total kidney volume (eTKV) increase with growth throughout childhood and adolescence despite individual variability. Height-adjusted PTP length decreases over time, but such a trend cannot be seen for height-adjusted eTKV (haeTKV) where we even observed a slight mean linear increase of 4.5 ml/m per year during childhood and adolescence for the overall cohort. Patients with two null PKHD1 variants had larger first documented haeTKV values than children with missense variants (median (IQR) haeTKV 793 (450-1098) ml/m in Null/null, 403 (260-538) ml/m in Null/mis, 230 (169-357) ml/m in Mis/mis). In the overall cohort, estimated glomerular filtration rate decreases with increasing haeTKV (median (IQR) haeTKV 210 (150-267) ml/m in CKD stage 1, 472 (266-880) ml/m in stage 5 without kidney replacement therapy). Strikingly, there is a clear correlation between haeTKV in the first eighteen months of life and kidney survival in childhood and adolescence with ten-year kidney survival rates ranging from 20% in patients of the highest to 94% in the lowest quartile. Early childhood haeTKV may become an easily obtainable prognostic marker of kidney disease in ARPKD, e.g. for the identification of patients for clinical studies.

PubMed Disclaimer

Conflict of interest statement

Dr. Liebau has received honoraria for scientific lectures from Pfizer. Representing the University Hospital of Cologne, Dr. Liebau has been counselling Otsuka in an advisory board. Dr. Mekahli, represented by KU Leuven University, received an educational grant from Otsuka and participated in an advisory board. The other authors declare no potential conflict of interest.

Figures

Figure 1
Figure 1
Sonographic findings over time: Average kidney pole-to-pole length (avPTP length) increases with body height (a), height-adjusted avPTP length decreases with age (b). Estimated total kidney volumes (eTKV) increase with body height (c), height-adjusted value (haeTKV) distribution is stable, although variable, in children (d). These findings were confirmed in a subset of patients in whom both haPTP length and haeTKV were available (e). The distribution of eTKV showed a similar relation to body height in different age groups (f).
Figure 2
Figure 2
Correlation of haeTKV to genetics and kidney function: HaeTKV values for different groups of genotypes. The first documented haeTKV value was used for each patient (a). eGFR and haeTKV show a loose inverse relation in the total cohort (b). Kaplan–Meier of kidney survival. The highest quartile of haeTKVmax18values shows poorest kidney outcome (c). Scatter plot and regression lines of eGFR values of haeTKVmax18 patients stratified according to haeTKVmax18 quartiles (d). Normalized yearly eGFR loss of haeTKVmax18 patients stratified according to haeTKVmax18 quartiles. Only patients with at least 3 visits spanning at least one year were used to obtain valid estimations (e).

References

    1. Bergmann C, et al. Polycystic kidney disease. Nat. Rev. Dis. Primer. 2018;4:50. doi: 10.1038/s41572-018-0047-y. - DOI - PMC - PubMed
    1. Guay-Woodford LM, et al. Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: Report of an international conference. J. Pediatr. 2014;165:611–617. doi: 10.1016/j.jpeds.2014.06.015. - DOI - PMC - PubMed
    1. Burgmaier K, et al. Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants. Kidney Int. 2021;100(3):650–659. doi: 10.1016/j.kint.2021.04.019. - DOI - PubMed
    1. Gimpel C, et al. Perinatal diagnosis, management, and follow-up of cystic renal diseases: A clinical practice recommendation with systematic literature reviews. JAMA Pediatr. 2018;172:74–86. doi: 10.1001/jamapediatrics.2017.3938. - DOI - PubMed
    1. Irazabal MV, et al. Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials. J. Am. Soc. Nephrol. 2015;26:160–172. doi: 10.1681/ASN.2013101138. - DOI - PMC - PubMed

Publication types

MeSH terms